Alfasigma acquires the rights to Lumeblue (TM) (methylene blue MMX) for EU sales and thereby consolidates its gastrointestinal portfolio
BOLOGNA, Italy, Feb. 6 / PRNewswire / – Cosmo Pharmaceuticals receives an advance payment of EUR 4 million to Alfasigma plus double-digit royalties Lumeblue (TM) … Read more